Tevogen Bio Holdings Inc.
Clinical-stage immunotherapy company developing off-the-shelf T cell therapies.
TVGN | US
Overview
Corporate Details
- ISIN(s):
- US88165K1016 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 15 INDEPENDENCE BOULEVARD, SUITE #210, 7059 WARREN
- Website:
- https://tevogen.com/
Description
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company developing off-the-shelf, precision T cell therapies. The company utilizes its proprietary ExacTcell™ technology platform to harness the therapeutic potential of CD8+ cytotoxic T lymphocytes (CTLs), a key component of the natural immune system. This platform is designed to create treatments that specifically target antigens present only on diseased cells, thereby preserving healthy tissue and enhancing safety through the use of naturally occurring T cell receptors. The company's development pipeline addresses significant unmet medical needs across multiple therapeutic areas, including oncology, virology, and neurology, with a stated goal of providing affordable and accessible personalized therapies to large patient populations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tevogen Bio Holdings Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tevogen Bio Holdings Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tevogen Bio Holdings Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
